Skip to main content
Nature Communications logoLink to Nature Communications
. 2020 Jan 29;11:673. doi: 10.1038/s41467-020-14429-3

Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

Lei Nie 1,#, Yongkun Wei 1,#, Fei Zhang 1,2, Yi-Hsin Hsu 1, Li-Chuan Chan 1,3, Weiya Xia 1, Baozhen Ke 1, Cihui Zhu 1, Rong Deng 1,4, Jun Tang 1,5, Jun Yao 1, Yu-Yi Chu 1, Xixi Zhao 1,6, Ye Han 1,7, Junwei Hou 1, Longfei Huo 1, How-Wen Ko 1,3, Wan-Chi Lin 1, Hirohito Yamaguchi 1,8, Jung-Mao Hsu 1, Yi Yang 1, Dean N Pan 1,9, Jennifer L Hsu 1,10,11, Celina G Kleer 12, Nancy E Davidson 13, Gabriel N Hortobagyi 14, Mien-Chie Hung 1,3,10,11,
PMCID: PMC6989459  PMID: 31996688

Correction to: Nature Communications 10.1038/s41467-019-13105-5, published online 8 November 2019.

The original version of this Article omitted the following funding source from the Acknowledgements:

CPRIT Research Training Program (RP101502, 140106, and 170067; to H.-W.K.). This has been corrected in the PDF and HTML versions of the Article.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES